BEST1 | Bestrophin 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
BEST3 | Bestrophin 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BFAR | Bifunctional apoptosis regulator | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BMPR2 | Bone morphogenetic protein receptor, type II (serine/threonine kinase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BRI3 | Brain protein I3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
BX649567.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf111 | Chromosome 10 open reading frame 111 | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf128 | Chromosome 10 open reading frame 128 | Predicted membrane proteins
| | | | | Mixed |
C14orf180 | Chromosome 14 open reading frame 180 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
C16orf58 | Chromosome 16 open reading frame 58 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C17orf62 | Chromosome 17 open reading frame 62 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C1orf101 | Chromosome 1 open reading frame 101 | Predicted membrane proteins
| | | | | Tissue enriched |
C1orf27 | Chromosome 1 open reading frame 27 | Predicted membrane proteins
| | | | | Expressed in all |
C1orf95 | Chromosome 1 open reading frame 95 | Predicted membrane proteins
| | | | | Tissue enhanced |
C20orf141 | Chromosome 20 open reading frame 141 | Predicted membrane proteins
| | | | | Tissue enriched |
C3orf52 | Chromosome 3 open reading frame 52 | Predicted membrane proteins
| | | | | Mixed |
C5orf28 | Chromosome 5 open reading frame 28 | Predicted membrane proteins
| | | | | Expressed in all |
C6orf136 | Chromosome 6 open reading frame 136 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C9orf69 | Chromosome 9 open reading frame 69 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C9orf91 | Chromosome 9 open reading frame 91 | Predicted membrane proteins
| | | | | Expressed in all |
CACFD1 | Calcium channel flower domain containing 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA2D3 | Calcium channel, voltage-dependent, alpha 2/delta subunit 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CACNG6 | Calcium channel, voltage-dependent, gamma subunit 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CAMLG | Calcium modulating ligand | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CATSPERD | Catsper channel auxiliary subunit delta | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CCDC109B | Coiled-coil domain containing 109B | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CCDC51 | Coiled-coil domain containing 51 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD200 | CD200 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD34 | CD34 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CECR6 | Cat eye syndrome chromosome region, candidate 6 | Predicted membrane proteins
| | | | | Group enriched |
CERS2 | Ceramide synthase 2 | Predicted membrane proteins
| | | | | Expressed in all |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CERS4 | Ceramide synthase 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CFAP54 | Cilia and flagella associated 54 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNB1 | Cholinergic receptor, nicotinic, beta 1 (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |